Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib for Preserving Beta-Cell Function in New-Onset Type 1 Diabetes
NCT01781975Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- Jan 2014
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of imatinib in type 1 diabetes mellitus (T1D), sponsored by University of California, San Francisco. Started Jan 2014; status: completed.
02
Drugs
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01781975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01781975.